Sanofi says Zaltrap approved in Europe for colorectal cancer
PARIS Feb 5 (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer.
The approval came after a recent late-stage study of the drug showed significant improvement in survival among patients with colon cancer.
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video